Assignment of Assignor's Interest

Recorded: 2014-06-11 Pages: 5

Assignor

THERAVANCE, INC.

Executed: 2014-06-01

Assignee

THERAVANCE BIOPHARMA R&D IP, LLC

901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA, USA 94080

Covered Properties (3)

Biphenyl Compounds Useful as Muscarinic Receptor Antagonists

Patent: 7,456,199 →

Application: 11/077,222 →

Publication: US 2005/0203139

Biphenyl Compounds Useful as Muscarinic Receptor Antagonists

Patent: 7,858,795 →

Application: 12/286,914 →

Publication: US 2009/0048299

Biphenyl compounds useful as muscarinic receptor antagonists

Application: 60/552,274 →

Related Assignments (2)

Other recorded transfers of the patents in this record — the chain of ownership.